AzTrials
AzTrials

CataractCaTNAPS-1NCT06506669

Cataract Monitored Anesthesia Care (MAC) Feasibility Pilot Study

A study testing Oral sedation in people with Cataract and Bilateral Senile Cataract, run by University of California, San Francisco at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this pilot clinical trial comparing two different sedation approaches for cataract surgery is to assess the feasibility, completeness, and distribution of data in measuring patient satisfaction, the quality of recovery, and surgical outcomes for the purpose of planning a larger clinical trial. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
Conditions the study is for
Cataract, Bilateral Senile Cataract, Anesthesia
What is being tested?
Oral sedation
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
23 participants
Where
1 siteUnited States
Study dates
12 Jun 2024to 29 May 2025
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • ≥ 60 years old
  • Capable of providing informed consent and completing the study procedures in English
  • Able to provide consent for oneself
  • Able to follow directions
  • Able to climb one flight of stairs without stopping to rest
  • Have a new diagnosis of cataract disease
  • Plan on having cataract surgery on their eye within the next 6 months

Who cannot join

  • History of prior cataract surgery
  • Admission to the hospital within the past 30 days
  • Difficulty being sedated during other minor outpatient procedures or imaging studies
  • Allergy or resistance to local anesthetic agents
  • Cannot lay flat on your back without having symptoms (i.e., difficulty breathing, severe back pain, etc.)
  • History of severe anxiety requiring routine use of benzodiazepines
Show all 16Show fewer
  • Severe valve disease (e.g., critical aortic stenosis)
  • Cardiac conditions requiring an implanted cardiac device such as a pacemaker, defibrillator, or left ventricular assist device (for arrhythmia, congestive heart failure, etc.)
  • Untreated chest pain or angina
  • Patients with movement disorders (e.g., Parkinson's Disease)
  • History of Cerebral Vascular Accident (CVA), Transient Ischemic Attack (TIA), or seizures
  • Require home oxygen (O2) at rest or with exertion
  • End-stage renal disease (ESRD) requiring dialysis
  • Morbid obesity (BMI>35)
  • Patient undergoing cataract surgery in combination with any other ophthalmologic procedure
  • Patient requiring general anesthesia during cataract surgery due to the underlying characteristics of the existing cataract and/or anticipated complexity of the planned procedure

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of California, San Francisco

    San Francisco, California, 94143

Other trials in United States

About this study

Official title: Comparing Two Normal Approaches to Procedural Sedation for Cataract Surgery: A Prospective, Feasibility Pilot Study

The goal of this pilot clinical trial comparing two different sedation approaches for cataract surgery is to assess the feasibility, completeness, and distribution of data in measuring patient satisfaction, the quality of recovery, and surgical outcomes for the purpose of planning a larger clinical trial. Participants will be asked to respond to several surveys throughout the study on their experience and to assess outcomes of interest.

Read the detailed description

This is a single-center, randomized, double-blinded, pilot clinical trial (n=20). Participants having first eye cataract surgery will be randomized to receive an oral benzodiazepine (intervention) or an oral placebo pill (control). The primary goal of this study is to assess the feasibility, completeness, and distribution of data in measuring patient satisfaction, quality of recovery, and surgical outcomes in participants receiving oral sedation versus oral placebo for cataract surgery. The secondary goals of this study are to assess success with recruitment, intervention fidelity, adherence to interventions and participant retention after interventions. Participants will be asked to respond to several surveys at key study timepoints regarding their sedation experiences and to assess outcomes of interest.

Being tested
Oral sedation, Placebo
Keywords
cataract surgery, oral sedation, intravenous sedation, conscious sedation, monitored anesthesia care, quality of recovery
Medical subject headings
Cataract, Patient Satisfaction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Oral sedationProcedure or surgery

    Oral medication for anxiolysis administered in the preoperative setting

  • PlaceboProcedure or surgery

    A placebo pill with no active ingredients administered in the preoperative setting

Study groups in NCT06506669
Study groupRoleWhat they receive
InterventionExperimentalOral sedation will be administered to patients prior to the procedure.
Receives: Procedure: Oral sedation
PlaceboPlacebo comparatorAn oral placebo pill will be administered to patients prior to the procedure.
Receives: Procedure: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With High Satisfaction (ISAS Score ≥ 2)

    The Iowa Satisfaction with Anesthesia Scale (ISAS) is an 11-item validated questionnaire assessing patient satisfaction with anesthesia care. Each item is scored from -3 to +3, and the total score is calculated as the mean of all items, resulting in a total score range of -3 to +3. Higher scores indicate greater satisfaction.

    For this analysis, high satisfaction is defined as an ISAS score ≥ 2.

    Measured: 30 minutes (PACU), 1 day (POD1), and 7 days after surgery (POD7)

Secondary outcomes (7)
  1. Number of Participants Meeting Eligibility Criteria at Screening

    Number of participants who met all eligibility criteria at the time of screening, out of the total number of participants assessed for eligibility

    Measured: At screening (prior to enrollment)

  2. Number of Participants Completing All Study Surveys at Each Timepoint

    Number of participants who completed all required study surveys at each postoperative timepoint (PACU, POD1, POD7), out of the number of participants assigned to each study arm

    Measured: 30 minutes (PACU), 1 day (POD1), and 7 days after surgery (POD7)

  3. Number of Participants Who Completed All Required Study Procedures

    Number of participants who completed all required study procedures from enrollment through the final postoperative follow-up visit, out of the total number of participants enrolled in the study

    Instruments:

    Iowa Satisfaction with Anesthesia Scale (ISAS) Postoperative Quality of Recovery Scale (PQRS) Quality of Recovery-15 (QoR-15) Functional Recovery Index (FRI)

    Measured: From enrollment through final study follow-up (POD7)

  4. Number of Participants With Sedation-Related Complications During 30-Day Postoperative Follow-up

    Number of participants experiencing at least one sedation-related complication within 30 days after surgery, out of the total number of participants enrolled in the study

    Measured: From enrollment through 30 days after surgery

  5. Number of Participants Achieving Recovery on the Postoperative Quality of Recovery Scale (PQRS)

    The Postoperative Quality of Recovery Scale (PQRS) assesses recovery across physiological, pain, emotional, cognitive, and activities of daily living domains.

    For this analysis, recovery is defined as meeting PQRS recovery criteria at each time point. Recovery is defined as a return to baseline performance in all assessed PQRS domains at each time point.

    Measured: 30 minutes (PACU), 1 day (POD1), and 7 days after surgery (POD7)

  6. Quality of Recovery-15 (QoR-15) Total Score After Surgery

    The Quality of Recovery-15 (QoR-15) is a validated 15-item questionnaire assessing postoperative recovery across physical comfort, emotional state, psychological support, and physical independence. Each item is scored from 0 to 10, and the total score is calculated by summing all items, resulting in a total score range of 0 to 150. Higher scores indicate better recovery.

    Measured: 1 day and 7 days after surgery

  7. Functional Recovery Index (FRI) Total Score After Surgery

    The Functional Recovery Index (FRI) is a validated 14-item questionnaire assessing postoperative functional recovery, including mobility and activities of daily living. Each item is scored and summed to produce a total score ranging from 0 to 100. Lower scores indicate better functional recovery.

    Measured: 1 day and 7 days after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jul 2024
  2. Study start12 Jun 2024
  3. Primary completion6 May 2025
  4. Study completion29 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
A single-center, randomized, double-blinded, randomized pilot clinical trial
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06506669
Sponsor's protocol ID
23-40367
Other IDs
5K23AG072035-03
Acronym
CaTNAPS-1
Status last verified
Jun 2026
First submitted
25 Jun 2024
Last updated
9 Jul 2026
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: This is a small single center pilot study so we do not plan to make individual participant data available to other researchers.

Publications

  • Chen CL, Lin GA, Bardach NS, Clay TH, Boscardin WJ, Gelb AW, Maze M, Gropper MA, Dudley RA. Preoperative medical testing in Medicare patients undergoing cataract surgery. N Engl J Med. 2015 Apr 16;372(16):1530-8. doi: 10.1056/NEJMsa1410846.

    PubMed 25875258
  • Chen CL, Clay TH, McLeod S, Chang HP, Gelb AW, Dudley RA. A Revised Estimate of Costs Associated With Routine Preoperative Testing in Medicare Cataract Patients With a Procedure-Specific Indicator. JAMA Ophthalmol. 2018 Mar 1;136(3):231-238. doi: 10.1001/jamaophthalmol.2017.6372.

    PubMed 29346472
  • Liu YC, Wilkins M, Kim T, Malyugin B, Mehta JS. Cataracts. Lancet. 2017 Aug 5;390(10094):600-612. doi: 10.1016/S0140-6736(17)30544-5. Epub 2017 Feb 25.

    PubMed 28242111
  • Norregaard, J. C. Results from the International Cataract Surgery Outcomes Study. Acta Ophthalmologica Scandinavica 85, 5-32, doi:10.1111/j.1600-0420.2007.00937.x (2007).

  • Kent, C. Cataract Surgery: Is an anesthesiologist necessary?, <https://www.reviewofophthalmology.com/article/cataract-surgery-is-an-anesthesiologist-necessary> (2009).

  • Andrews, M. Anthem Calls On Eye Surgeons To Monitor Anesthesia During Cataract Surgery, <https://khn.org/news/anthem-calls-on-eye-surgeons-to-monitor-anesthesia-during-cataract-surgery/> (2018).

  • Ianchulev T, Litoff D, Ellinger D, Stiverson K, Packer M. Office-Based Cataract Surgery: Population Health Outcomes Study of More than 21 000 Cases in the United States. Ophthalmology. 2016 Apr;123(4):723-8. doi: 10.1016/j.ophtha.2015.12.020. Epub 2016 Jan 22.

    PubMed 26804760
  • Zakrzewski PA, Friel T, Fox G, Braga-Mele R. Monitored anesthesia care provided by registered respiratory care practitioners during cataract surgery: a report of 1957 cases. Ophthalmology. 2005 Feb;112(2):272-7. doi: 10.1016/j.ophtha.2004.08.016.

    PubMed 15691563
  • Kent-Smith BT, Wallace GM. Routine cataract surgery without the presence of an anaesthetist. Clin Exp Ophthalmol. 2007 Aug;35(6):589. doi: 10.1111/j.1442-9071.2007.01553.x. No abstract available.

    PubMed 17760646
  • Murray P, Adams K, Haddad P, Murray N, O'Rourke M. The routine requirement for anaesthetists in local anaesthetic cataract surgery. Clin Exp Ophthalmol. 2007 Mar;35(2):195-6. doi: 10.1111/j.1442-9071.2006.01441.x. No abstract available.

    PubMed 17362468
  • Zakrzewski PA, Banashkevich AV, Friel T, Braga-Mele R. Monitored anesthesia care by registered respiratory therapists during cataract surgery: an update. Ophthalmology. 2010 May;117(5):897-902. doi: 10.1016/j.ophtha.2009.10.005. Epub 2010 Jan 15.

    PubMed 20079927
  • Basta B, Gioia L, Gemma M, Dedola E, Bianchi I, Fasce F, Beretta L. Systemic adverse events during 2005 phacoemulsifications under monitored anesthesia care: a prospective evaluation. Minerva Anestesiol. 2011 Sep;77(9):877-83.

    PubMed 21878869
  • Koolwijk J, Fick M, Selles C, Turgut G, Noordergraaf JI, Tukkers FS, Noordergraaf GJ. Outpatient cataract surgery: incident and procedural risk analysis do not support current clinical ophthalmology guidelines. Ophthalmology. 2015 Feb;122(2):281-7. doi: 10.1016/j.ophtha.2014.08.030. Epub 2014 Oct 22.

    PubMed 25444350
  • Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, Fleisher LA, Schein OD. Injectable versus topical anesthesia for cataract surgery: patient perceptions of pain and side effects. The Study of Medical Testing for Cataract Surgery study team. Ophthalmology. 2000 Nov;107(11):2054-60. doi: 10.1016/s0161-6420(00)00359-6.

    PubMed 11054331
  • Katz J, Feldman MA, Bass EB, Lubomski LH, Tielsch JM, Petty BG, Fleisher LA, Schein OD; Study of Medical Testing for Cataract Surgery Study Team. Adverse intraoperative medical events and their association with anesthesia management strategies in cataract surgery. Ophthalmology. 2001 Oct;108(10):1721-6. doi: 10.1016/s0161-6420(01)00704-7.

    PubMed 11581040

Questions about this trial

What is this clinical trial studying?

A study testing Oral sedation in people with Cataract and Bilateral Senile Cataract, run by University of California, San Francisco at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 9 Jul 2026). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With High Satisfaction (ISAS Score ≥ 2) (time frame: 30 minutes (PACU), 1 day (POD1), and 7 days after surgery (POD7)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06506669, which also lists 51 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in